​

Funding Round

Series A - CellFE

Series A - CellFE

Investment Firm

Overview

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

Announced Date

Sep 27, 2023

Closed on Date

Sep 27, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

M Ventures

M Ventures

M Ventures is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

8

Investor Name
Participant InvestorRiverine Ventures
Participant InvestorElm Street Ventures
Participant InvestorGreatPoint Ventures
Participant InvestorCota Capital
Participant InvestorKhosla Ventures

Round Details and Background

CellFE raised $22000000 on 2023-09-27 in Series A

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 16, 2020
Seed Round - CellFE
5-4.8M
Sep 01, 2018
Non Equity Assistance - CellFE
1-undefined
Sep 27, 2023
Series A - CellFE
9-22.0M

Recent Activity

There is no recent news or activity for this profile.